Atengen

Atengen is a biotechnology company providing a therapeutic target that is expressed specifically in tumor blood vessels of most types of solid tumors. It uses technologies to identify several drug candidates that suppress tumor growth by inhibiting new blood vessel growth and cause extensive tumor necrosis by killing existing tumor blood vessels.